Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 26.51
+0.42 (1.61%)
May 12, 2026, 3:04 PM CST
SHE:002880 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 233.01 | 245.79 | 253.52 | 218.65 | 117.52 | 205.44 |
Depreciation & Amortization | 154.5 | 154.5 | 116.77 | 87.31 | 65.26 | 55.48 |
Other Amortization | 4.9 | 4.9 | 3.67 | 2.13 | 1.59 | 1.29 |
Loss (Gain) From Sale of Assets | - | - | -0.05 | - | -0.04 | - |
Asset Writedown & Restructuring Costs | -1.83 | -1.83 | -0.1 | 0.1 | 0.43 | 0.32 |
Loss (Gain) From Sale of Investments | -4.76 | -4.76 | 8.53 | -7.8 | -18.68 | -0.74 |
Provision & Write-off of Bad Debts | - | - | 4.08 | -2.5 | -1.34 | 1.11 |
Other Operating Activities | -79.32 | 46.72 | 24.46 | 12.95 | 6.52 | 3.1 |
Change in Accounts Receivable | -330.44 | -330.44 | -144.48 | 88.21 | 33.52 | -2.72 |
Change in Inventory | -92.87 | -92.87 | -119.9 | -50.56 | -183.83 | -37.76 |
Change in Accounts Payable | 239.45 | 239.45 | 35.01 | 35.62 | -20.06 | 20.25 |
Change in Other Net Operating Assets | 15.23 | 15.23 | -3.51 | 20.86 | - | - |
Operating Cash Flow | 124.36 | 263.18 | 177.77 | 397.94 | 1.2 | 246.89 |
Operating Cash Flow Growth | -40.98% | 48.05% | -55.33% | 33088.09% | -99.51% | -18.78% |
Capital Expenditures | -164.28 | -169.69 | -255.5 | -328.85 | -327.37 | -240.83 |
Sale of Property, Plant & Equipment | 0.03 | 0.04 | 0.17 | 0.07 | 0.12 | 0.23 |
Cash Acquisitions | - | - | - | -22.39 | - | - |
Investment in Securities | -16.5 | - | 15 | -1 | -160 | -49.48 |
Other Investing Activities | -280.56 | -85.27 | 2.13 | - | -0 | - |
Investing Cash Flow | -461.3 | -254.92 | -238.2 | -352.17 | -487.26 | -290.08 |
Long-Term Debt Issued | - | 421.31 | 252.76 | 179.97 | 528.48 | 75 |
Total Debt Issued | 472.2 | 421.31 | 252.76 | 179.97 | 528.48 | 75 |
Long-Term Debt Repaid | - | -450.5 | -103.16 | -202.55 | -26.39 | -133.35 |
Total Debt Repaid | -481 | -450.5 | -103.16 | -202.55 | -26.39 | -133.35 |
Net Debt Issued (Repaid) | -8.8 | -29.19 | 149.6 | -22.58 | 502.09 | -58.35 |
Issuance of Common Stock | - | - | - | - | - | 4 |
Common Dividends Paid | -64.41 | -65.73 | -65.88 | -65.6 | -57.68 | -41.82 |
Other Financing Activities | 180.89 | 180.91 | - | - | 3.5 | - |
Financing Cash Flow | 107.68 | 85.99 | 83.72 | -88.18 | 447.9 | -96.18 |
Net Cash Flow | -229.26 | 94.25 | 23.29 | -42.41 | -38.16 | -139.37 |
Free Cash Flow | -39.92 | 93.49 | -77.73 | 69.08 | -326.17 | 6.06 |
Free Cash Flow Growth | - | - | - | - | - | -94.72% |
Free Cash Flow Margin | -3.16% | 7.38% | -6.46% | 6.59% | -48.83% | 0.67% |
Free Cash Flow Per Share | -0.18 | 0.41 | -0.34 | 0.30 | -1.44 | 0.03 |
Cash Interest Paid | - | - | - | - | 1.11 | - |
Cash Income Tax Paid | 123.17 | 107.17 | 85.12 | 72.15 | 16.25 | 71.17 |
Levered Free Cash Flow | -33.05 | 61.44 | -150.43 | 12.4 | -372.74 | -22.58 |
Unlevered Free Cash Flow | -33.05 | 61.44 | -136.72 | 21.36 | -371.45 | -21.41 |
Change in Working Capital | -182.13 | -182.13 | -233.12 | 87.09 | -170.05 | -19.12 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.